semaglutide and als Wegovy for the Treatment of Chronic Weight Management, US Biohaven's ALS drug fails to

More recently, the term diabetic gastroparesis (DGp) has been used to describe a serious complication of diabetes resulting in delayed gastric emptying with associated upper gastrointestinal (GI) symptoms in the absence of any mechanical obstruction [2]

Nausea, vomiting, diarrhea, constipation, abdominal symptoms, and reduced appetite have appeared in clinical research

Medical research is advancing towards more personalised medical strategies, with growing acknowledgement that responses by patients to GLP-1 receptor agonists might differ markedly

Step 4: Begin monitoring and support

Youll sign informed consent forms and receive guidance on lifestyle adjustments to support the therapy